CFR
- Title 1 - General Provisions
- Title 2 - Grants and Agreements
- Title 3 - The President
- Title 4 - Accounts
- Title 5 - Administrative Personnel
- Title 6 - Domestic Security
- Title 7 - Agriculture
- Title 8 - Aliens and Nationality
- Title 9 - Animals and Animal Products
- Title 10 - Energy
- Title 11 - Federal Elections
- Title 12 - Banks and Banking
- Title 13 - Business Credit and Assistance
- Title 14 - Aeronautics and Space
- Title 15 - Commerce and Foreign Trade
- Title 16 - Commercial Practices
- Title 17 - Commodity and Securities Exchanges
- Title 18 - Conservation of Power and Water Resources
- Title 19 - Customs Duties
- Title 20 - Employees' Benefits
- Title 21 - Food and Drugs
- Title 22 - Foreign Relations
- Title 23 - Highways
- Title 24 - Housing and Urban Development
- Title 25 - Indians
- Title 26 - Internal Revenue
- Title 27 - Alcohol, Tobacco Products and Firearms
- Title 28 - Judicial Administration
- Title 29 - Labor
- Title 30 - Mineral Resources
- Title 31 - Money and Finance: Treasury
- Title 32 - National Defense
- Title 33 - Navigation and Navigable Waters
- Title 34 - Education
- Title 35 - Panama Canal
- Title 36 - Parks, Forests, and Public Property
- Title 37 - Patents, Trademarks, and Copyrights
- Title 38 - Pensions, Bonuses, and Veterans' Relief
- Title 39 - Postal Service
- Title 40 - Protection of Environment
- Title 41 - Public Contracts and Property Management
- Title 42 - Public Health
- Title 43 - Public Lands: Interior
- Title 44 - Emergency Management and Assistance
- Title 45 - Public Welfare
- Title 46 - Shipping
- Title 47 - Telecommunication
- Title 48 - Federal Acquisition Regulations System
- Title 49 - Transportation
- Title 50 - Wildlife and Fisheries
SUBPART A—General Labeling Provisions (§201.1 to §201.26)
- 201.1—Drugs; name and place of business of manufacturer, packer, or distributor.
- 201.2—Drugs and devices; National Drug Code numbers.
- 201.5—Drugs; adequate directions for use.
- 201.6—Drugs; misleading statements.
- 201.10—Drugs; statement of ingredients.
- 201.15—Drugs; prominence of required label statements.
- 201.16—Drugs; Spanish-language version of certain required statements.
- 201.17—Drugs; location of expiration date.
- 201.18—Drugs; significance of control numbers.
- 201.19—Drugs; use of term “infant”.
- 201.20—Declaration of presence of FD&C Yellow No. 5 and/or FD&C Yellow No. 6 in certain drugs for human use.
- 201.21—Declaration of presence of phenylalanine as a component of aspartame in over-the-counter and prescription drugs for human use.
- 201.22—Prescription drugs containing sulfites; required warning statements.
- 201.23—Required pediatric studies.
- 201.24—Labeling for systemic antibacterial drug products.
- 201.25—Bar code label requirements.
- 201.26—Exceptions or alternatives to labeling requirements for human drug products held by the Strategic National Stockpile.
Tips